Key facts
- This page summarizes Ivan Tornos's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Mar 2025, 17:35.
Ivan Tornos - 06 Mar 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ZBH
- Reported as of
- 06 Mar 2025
- Net transaction value
- -$595,500
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2025, 17:35:54 UTC
- Prior SEC filing
- 27 Feb 2025
- Next SEC filing
- 23 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Tornos filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 07 Mar 2025.
Change
- Previous filing in this sequence was filed on 27 Feb 2025.
- Current net transaction value: -$595,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +10,268
- Change %
- +22%
- Price
- $0.000000
- Shares after
- 57,432
- Date
- 06 Mar 2025
- Ownership
- Direct
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $595,500
- Shares
- -5,679
- Change %
- -9.9%
- Price
- $104.86
- Shares after
- 51,753
- Date
- 06 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -10,268
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 10,268
- Date
- 06 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,268
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
Footnote F2
Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
Footnote F3
10,268 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026